BSE filing, NSE: ELPROINTL. Summary written from the filing by ALFA Finder's alert engine.
Elpro International Ltd: key numbers
- Share price
- ₹165.00
- Market cap
- ₹2,796 Cr
- Revenue (annual)
- ₹528.1 Cr
- Net profit (annual)
- ₹87.37 Cr
- P/E (TTM)
- 21.6×Sector 34.0×
- Promoter holding
- 93.02%+18.02% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Elpro International Ltd
All →Elpro International Other Announcement
Elpro International Ltd. submitted the mandatory quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Elpro International Annual General Meeting
Elpro International Limited concluded its 63rd Annual General Meeting on September 30, 2026. Shareholders approved the adoption of FY26 financial statements and the re-appointment of Mr. Sunil Khandelwal.
Elpro International Annual General Meeting
Elpro International Ltd has issued the notice for its 63rd Annual General Meeting, scheduled for September 30, 2026, alongside the Annual Report 2025-26.
Elpro International Acquisition Worth ₹186.1 Cr
Elpro International’s subsidiary acquired a 100% stake in Quest Academy Limited for ₹186.12 Crore. This acquisition expands the company’s real estate portfolio.
- Value
- ₹186.1 Cr
Elpro International Share Pledge
Promoter I G E (India) Pvt Ltd disclosed share encumbrances in Elpro International Ltd to secure debt facilities aggregating ₹420 Crore.
- Value
- ₹420.0 Cr
Elpro International Q1 FY27 Results: Net Profit ₹116.1 Cr, Up 56.3% YoY
Elpro International Ltd reported revenue from operations of ₹138.7 Cr (+39.1% YoY) and net profit of ₹116.1 Cr (+56.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹116.1 Cr · +56.3% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.